The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing. The Garnet Valley site will focus on developing small molecule
PCI provides a full service Returns Management service for our clients, providing visibility and accountability in returning investigational drug product from investigational sites at the conclusion of a
Both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) had granted Orphan Drug Designation to BPS-804 for osteogenesis imperfecta, a rare, chronic genetic
CT900 is a targeted therapy that combines targeting folate receptor α (FRα) and inhibiting thymidylate synthase. The small molecule compound selectively enters cancer cells that over express folate
MEI Pharma chief medical officer Robert Mass said: “We are excited to be working with BeiGene to explore the potential of ME-401 in combination with zanubrutinib. “Combinatorial approaches
While Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor, COM701 is an investigational anti-PVRIG antibody. Apart from the clinical trial collaboration, Bristol-Myers Squibb has agreed to make
Silence received a notice of intention to grant from the European Patent Office for patent application EP 3 222 724B, further strengthening its innovative chemical modification technology patent
Cinfa Biotech, which was founded in 2013, has offices in Munich, Germany and Pamplona, Spain. The company, which is part of Spanish pharma firm Cinfa Group, is engaged
The Depletion of serum amyloid P component in Alzheimer’s disease (DESPIAD) trial will test whether a drug called miridesap removes a protein associated with the disease from the
The confirmation came from the new sub-analysis data from the Euro-Esli study of eslicarbazepine acetate for focal-onset seizures in more than 2,000 patients. Bial and Eisai said that
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.